Sarcoma Awareness Month sheds light on rare cancers, emphasizing early detection, research advancement, and patient support.

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces it has engaged Enclave Capital LLC ( ...

We all know a mother, a sister, a friend, a neighbor, who has battled breast cancer. For far too many, that story ends in heartbreak, not healing. “Strengthening the Implementation of the Global ...

BDC+ are facilities that deliver quality care, safely and effectively, in addition to demonstrating more affordable care. BDC+ designated facilities also achieve cost savings of 23% for spine surgery ...

In the pre-immunotherapy cohort, 80 patients were identified, 45% of whom had high NLR. ES-SCLC was present in nearly 69%, and all patients had a history of smoking.

Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?

When she was first diagnosed with inoperable skin cancer, Jackie Summers was told she was facing at least two years of treatment to try to control the disease and help any symptoms.

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI Frankfurt in October 2025.

“Basically, immunotherapy uses your natural defenses to battle the cancer,” said Kurra. “We have had great success with immunotherapy, especially in later stage cancers.